Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMG3 pseudogene 1 (PSMG3P1) is a human pseudogene that is related to the protein-coding gene Proteasome assembly chaperone 3 (PSMG3)[6][7]. Pseudogenes like PSMG3P1 are generally non-coding genomic elements, representing copies or remnants of functional genes that have acquired disabling mutations, preventing them from producing functional proteins[5][6]. PSMG3P1 itself has no known biological function, is not a therapeutic or molecular pharmacological target, and is not directly linked to disease or drug response based on available resources[6][7]. There are no reported protein products or direct disease associations for PSMG3P1. While some pseudogenes can have regulatory effects on related genes or act through non-coding RNA mechanisms, there is no specific evidence for such functions for PSMG3P1 in the current literature[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PSMG3 pseudogene 1 (PSMG3P1).